Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.89
|
1.90
|
1.93
|
1.89
|
1.93
|
1.91
|
|
|
176 070.25
|
622.00
|
1.84
|
2.00
|
1.85
|
1.84
|
1.92
|
1.915
|
|
|
136 596.65
|
794.00
|
1.78
|
1.93
|
1.93
|
1.83
|
1.93
|
1.84
|
|
|
157 537.27
|
1 289.00
|
1.83
|
1.87
|
1.88
|
1.81
|
1.94
|
1.88
|
|
|
339 956.80
|
1 129.00
|
1.82
|
2.10
|
1.83
|
1.81
|
1.98
|
1.87
|
|
|
433 121.53
|
1 649.00
|
1.71
|
1.96
|
1.88
|
1.71
|
1.90
|
1.78
|
|
|
362 229.91
|
1 621.00
|
1.75
|
1.95
|
1.84
|
1.81
|
1.95
|
1.88
|
|
|
294 305.38
|
1 308.00
|
1.80
|
1.98
|
2.11
|
1.70
|
2.11
|
1.84
|
|
|
889 734.08
|
2 792.00
|
1.92
|
2.12
|
2.01
|
1.94
|
2.13
|
2.11
|
|
|
267 457.93
|
1 246.00
|
2.01
|
2.11
|
2.13
|
1.96
|
2.13
|
2.00
|
|
|
343 140.79
|
1 438.00
|
Aadi Bioscience Inc (formerly Aerpio Pharmaceuticals Inc) is a developer of albumin-bound drugs designed to realize the full potential of mTOR inhibition by highly efficient target suppression in mTOR-driven diseases and biomarker-driven patient populations. The company is engaged in developing drugs that help in high tumour penetration due to mechanisms of albumin uptake in tumours and other areas with tissue remodelling or inflammation, enabling patients to block the activity of a protein called mTOR, which is known to be overactive in PEComa cancer cells.